Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

665 ARTÍCULOS , VIENDO DEL 271 AL 285

Alzheimer's disease: From immunotherapy to immunoprevention

Jucker M, Walker LC.

Cell. 2023 Sep 28;186(20):4260-4270. doi: 10.1016/j.cell.2023.08.021. Epub 2023 Sep 19.

Transcriptomics Meta-Analysis Reveals Phagosome and Innate Immune System Dysfunction as Potential Mechanisms in the Cortex of Alzheimer's Disease Mouse Strains

Widjaya MA, Liu CH, Lee SD, Cheng WC.

J Mol Neurosci. 2023 Oct;73(9-10):773-786. doi: 10.1007/s12031-023-02152-9. Epub 2023 Sep 21.

News & views: anti-amyloid antibodies and novel emerging approaches to Alzheimer's disease in 2023

Gandy S.

Mol Neurodegener. 2023 Sep 25;18(1):66. doi: 10.1186/s13024-023-00656-x.

Review of PINK1-Parkin-mediated mitochondrial autophagy in Alzheimer's disease

Zhou TY, Ma RX, Li J, Zou B, Yang H, Ma RY, Wu ZQ, Li J, Yao Y.

Eur J Pharmacol. 2023 Nov 15;959:176057. doi: 10.1016/j.ejphar.2023.176057. Epub 2023 Sep 24.

Treatment of Alzheimer's Disease: Beyond Symptomatic Therapies

Buccellato FR, D'Anca M, Tartaglia GM, Del Fabbro M, Scarpini E, Galimberti D.

Int J Mol Sci. 2023 Sep 9;24(18):13900. doi: 10.3390/ijms241813900.

Fisetin-In Search of Better Bioavailability-From Macro to Nano Modifications: A Review

Szymczak J, Cielecka-Piontek J.

Int J Mol Sci. 2023 Sep 15;24(18):14158. doi: 10.3390/ijms241814158.

Licochalcone A: A Potential Multitarget Drug for Alzheimer's Disease Treatment

Olloquequi J, Ettcheto M, Cano A, Fortuna A, Bicker J, Sánchez-Lopez E, Paz C, Ureña J, Verdaguer E, Auladell C, Camins A.

Int J Mol Sci. 2023 Sep 16;24(18):14177. doi: 10.3390/ijms241814177.

d-Amino acids: new clinical pathways for brain diseases

Souza INO, Roychaudhuri R, de Belleroche J, Mothet JP.

Trends Mol Med. 2023 Dec;29(12):1014-1028. doi: 10.1016/j.molmed.2023.09.001. Epub 2023 Sep 26.

Metal ion mediated aggregation of Alzheimer's disease peptides and proteins in solutions and at surfaces

Feng J, She Y, Li C, Shen L.

Adv Colloid Interface Sci. 2023 Oct;320:103009. doi: 10.1016/j.cis.2023.103009. Epub 2023 Sep 25.

The role of N-methyl-D-aspartate glutamate receptors in Alzheimer's disease: From pathophysiology to therapeutic approaches

Liu W, Li Y, Zhao T, Gong M, Wang X, Zhang Y, Xu L, Li W, Li Y, Jia J.

Prog Neurobiol. 2023 Dec;231:102534. doi: 10.1016/j.pneurobio.2023.102534. Epub 2023 Sep 30.

Clinical trials of new drugs for Alzheimer disease: a 2020-2023 update

Huang LK, Kuan YC, Lin HW, Hu CJ.

J Biomed Sci. 2023 Oct 2;30(1):83. doi: 10.1186/s12929-023-00976-6.

Neuroproteomic mapping of kinases and their substrates downstream of acetylcholine: finding and implications

Yamahashi Y, Tsuboi D, Funahashi Y, Kaibuchi K.

Expert Rev Proteomics. 2023 Jul-Dec;20(11):291-298. doi: 10.1080/14789450.2023.2265067. Epub 2023 Oct 30.

Friends and Foes in Alzheimer's Disease

Pauwels EKJ, Boer GJ.

Med Princ Pract. 2023;32(6):313-322. doi: 10.1159/000534400. Epub 2023 Oct 3.

Inflammatory signaling pathways in the treatment of Alzheimer's disease with inhibitors, natural products and metabolites (Review)

Zheng Y, Zhang X, Zhang R, Wang Z, Gan J, Gao Q, Yang L, Xu P, Jiang X.

Int J Mol Med. 2023 Nov;52(5):111. doi: 10.3892/ijmm.2023.5314. Epub 2023 Oct 6.

Advances in the discovery of heterocyclic-based drugs against Alzheimer's disease

Sánchez JD, Alcántara AR, González JF, Sánchez-Montero JM.

Expert Opin Drug Discov. 2023 Jul-Dec;18(12):1413-1428. doi: 10.1080/17460441.2023.2264766. Epub 2023 Nov 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias